FDA Director General Muhammad Asif Chaudhry Directs Prompt Resolution of Katchi Abadi Issues, Orders Strict Action Against Illegal Commercialization

Faisalabad 1 Oct (DIGITAL ITLA) Director General FDA Muhammad Asif Chaudhry has instructed relevant officers and staff to provide immediate relief to applicants regarding issues concerning Katchi Abadis and to maintain strict vigilance over illegal commercialization activities within these settlements. He made it clear that departmental action must be taken without delay in case of violations to safeguard citizens' rights and ensure compliance with relevant rules and regulations. He issued these directives during an open-door policy session held under the directions of the Punjab Government to hear public grievances and complaints.

The session was attended by Additional Director General Qaiser Abbas Rind, Chief Engineer Mehr Ayub, Director IT Yasir Ijaz Chatha, Director Town Planning Asma Mohsin, Director Estate Management Junaid Hassan Munj, Deputy Director Katchi Abadi Afzal Ansari, and other concerned officers. DG FDA Muhammad Asif Chaudhry listened in detail to individual public complaints, applications, and challenges, issuing immediate spot directives to relevant officials for their resolution. He directed that citizens be provided relief on merit and in accordance with rules, avoiding unnecessary delays and bureaucratic red tape in official business. Specifically, he ordered that the execution of court decrees and the registration of property inheritance transfers be expedited so that applicants do not face unjustified waiting times.

The DG FDA also directed that the ongoing operation against illegal housing schemes be made more effective and result-oriented, calling for strict legal and departmental action against unauthorized constructions, encroachments, and the land mafia. He instructed estate management officers to promptly address public complaints regarding encroachments and urged related departments to continue their operations with mutual coordination and responsibility to curb illegal activities. Furthermore, he directed the Additional Director General to regularly review the progress of departmental actions on public applications, ensuring immediate accountability of negligent or dishonest staff.

Interacting with the applicants, Muhammad Asif Chaudhry expressed his firm resolve that prioritizing timely relief, transparency, and the swift redressal of public grievances is the core focus of the FDA. He noted that the direct hearing of citizens under the open-door policy aims to accelerate problem-solving and further enhance the institution's performance. The citizens appreciated and thanked the DG FDA for listening attentively to their grievances, issuing prompt orders, and taking effective measures for their relief.